Australia's Opyl jumps as brand signs patient recruitment contract

Pathkey.AI

05/02/2024 04:19

** Shares of Opyl  OPL.AX  rise 7.1% to A$0.03
    ** Healthcare software provider says its brand Opin has
signed a contract with Medtryx, the Australian contractor for
U.S.-based Lumen Bioscience
    ** Contract to support recruitment and onboarding of
patients for Lumen Bioscience's study on traveller's diarrhoea,
valued at A$282,000 ($183,469.20)
    ** About 370,000 shares change hands, compared with the
30-day average volume of 195,012
    ** Stock rose 0.7% in 2023 and is up 7.1% this year so far

($1 = 1.5370 Australian dollars)

 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))